Jeffrey H Miner Selected Research

laminin beta2 (S-laminin)

9/2011	Forced expression of laminin beta1 in podocytes prevents nephrotic syndrome in mice lacking laminin beta2, a model for Pierson syndrome.
3/2006	Transgenic isolation of skeletal muscle and kidney defects in laminin beta2 mutant mice: implications for Pierson syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jeffrey H Miner Research Topics

Disease

21	Hereditary Nephritis (Alport Syndrome) 03/2022 - 02/2001
21	Proteinuria 01/2021 - 03/2003
11	Renal Insufficiency (Renal Failure) 01/2019 - 07/2006
10	Nephrotic Syndrome (Syndrome, Nephrotic) 12/2021 - 05/2011
10	Kidney Diseases (Kidney Disease) 01/2020 - 01/2003
9	Pierson syndrome 01/2021 - 03/2006
7	Albuminuria 01/2021 - 08/2008
6	Neoplasms (Cancer) 01/2021 - 01/2005
5	Nephritis 02/2013 - 08/2002
4	Inborn Genetic Diseases (Disease, Hereditary) 01/2021 - 10/2014
4	Diabetic Nephropathies (Diabetic Nephropathy) 01/2021 - 01/2016
3	Chronic Kidney Failure (Chronic Renal Failure) 01/2021 - 04/2011
3	Inflammation (Inflammations) 01/2021 - 12/2009
2	Hematuria 01/2021 - 04/2010
2	Cerebral Hemorrhage 12/2019 - 04/2006
2	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 12/2019 - 01/2006
2	Wounds and Injuries (Trauma) 08/2017 - 01/2016
2	Muscular Dystrophies (Muscular Dystrophy) 03/2017 - 01/2009
2	Hypertension (High Blood Pressure) 03/2016 - 01/2006
2	Glomerulonephritis 10/2014 - 02/2013
2	Ichthyosis prematurity syndrome 02/2013 - 04/2011
2	Polycystic Kidney Diseases (Polycystic Kidney Disease) 04/2010 - 07/2006
2	Anti-Glomerular Basement Membrane Disease (Goodpasture's Syndrome) 12/2009 - 12/2005
2	Progeria (Hutchinson Gilford Syndrome) 09/2007 - 09/2005
2	Wilms Tumor (Wilm's Tumor) 03/2007 - 08/2002
1	Fibrosis (Cirrhosis) 01/2021
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Chronic Renal Insufficiency 01/2021
1	Sclerosis 01/2021
1	Growth Disorders 01/2020
1	Brain Injuries (Brain Injury) 12/2019
1	Rare Diseases (Rare Disease) 11/2019
1	Ichthyosis (Xeroderma) 01/2019
1	Netherton Syndrome 01/2019
1	Ischemic Stroke 01/2019
1	Reperfusion Injury 01/2019
1	Benign Familial Hematuria 10/2018
1	Membranous Glomerulonephritis (Membranous Nephropathy) 01/2018
1	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 11/2017
1	Rheumatoid Arthritis 11/2017
1	Edema (Dropsy) 10/2017

Drug/Important Bio-Agent (IBA)

16	CollagenIBA 03/2022 - 08/2002
15	Laminin (Merosin)IBA 01/2021 - 02/2001
14	Proteins (Proteins, Gene)FDA Link 12/2021 - 08/2002
6	Collagen Type IV (Type IV Collagen)IBA 01/2020 - 04/2006
5	AlbuminsIBA 01/2020 - 08/2006
5	Protein Isoforms (Isoforms)IBA 12/2019 - 03/2003
5	AntibodiesIBA 01/2018 - 02/2001
4	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2019 - 04/2014
4	prelamin AIBA 04/2008 - 09/2005
3	AutoantibodiesIBA 01/2018 - 12/2005
3	Antigen-Antibody Complex (Immune Complex)IBA 01/2018 - 05/2014
3	Immunoglobulin G (IgG)IBA 01/2018 - 02/2013
3	Fatty Acid Transport Proteins (Fatty Acid Transport Protein)IBA 02/2013 - 04/2003
3	laminin alpha5IBA 04/2010 - 06/2002
3	Lamin Type A (Lamin A)IBA 09/2007 - 09/2005
2	CreatinineIBA 01/2021 - 01/2020
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 06/2015
2	LipidsIBA 01/2021 - 01/2019
2	Biological ProductsIBA 01/2020 - 12/2019
2	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 01/2018 - 05/2014
2	Phosphotransferases (Kinase)IBA 01/2018 - 11/2017
2	Complement System Proteins (Complement)IBA 01/2018 - 05/2014
2	AntigensIBA 11/2017 - 05/2014
2	MicroRNAs (MicroRNA)IBA 10/2017 - 11/2008
2	Triglycerides (Triacylglycerol)IBA 01/2016 - 03/2009
2	IntegrinsIBA 10/2013 - 05/2006
2	IsoantibodiesIBA 02/2013 - 12/2005
2	antiglomerular basement membrane antibodyIBA 02/2013 - 12/2005
2	laminin beta2 (S-laminin)IBA 09/2011 - 03/2006
2	Fatty Acids (Saturated Fatty Acids)IBA 04/2011 - 04/2003
2	Heparitin Sulfate (Heparan Sulfate)IBA 07/2009 - 08/2008
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2006 - 03/2003
1	nanolucIBA 03/2022
1	Losartan (Cozaar)FDA LinkGeneric 01/2021
1	Heparin (Liquaemin)FDA LinkGeneric 01/2021
1	Discoidin Domain Receptor 1IBA 01/2021
1	Ezetimibe (Zetia)FDA Link 01/2021
1	Metformin (Glucophage)FDA LinkGeneric 01/2021
1	Collagen Type I (Type I Collagen)IBA 01/2021
1	Ramipril (Altace)FDA LinkGeneric 01/2021
1	Extracellular Matrix ProteinsIBA 12/2019
1	LipoxygenasesIBA 01/2019
1	Lipase (Acid Lipase)FDA Link 01/2019
1	Neuroprotective AgentsIBA 01/2019
1	Tight Junction ProteinsIBA 01/2019
1	Angiotensin Receptor AntagonistsIBA 01/2019
1	EnzymesIBA 01/2019
1	RNA (Ribonucleic Acid)IBA 01/2018
1	Complement Factor B (Factor B)IBA 01/2018
1	LectinsIBA 01/2018
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 12/2017
1	Neuropilin-1IBA 12/2017
1	CytokinesIBA 11/2017
1	Interleukin-13IBA 11/2017
1	Interleukin-4 (Interleukin 4)IBA 11/2017
1	MorpholinosIBA 10/2017
1	ActomyosinIBA 08/2017

Therapy/Procedure

12	Therapeutics 03/2022 - 03/2009
2	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2020 - 03/2006